EARNZ (EARN) Competitors GBX 5.30 -0.25 (-4.50%) (As of 12/20/2024 04:46 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider Trades EARN vs. AKR, TPG, APPS, MTR, PEB, WINV, CPT, CYS, MRS, and ORMShould you be buying EARNZ stock or one of its competitors? The main competitors of EARNZ include Akers Biosciences (AKR), TP Group (TPG), Appscatter Group (APPS), Metal Tiger (MTR), Pebble Beach Systems Group (PEB), Worsley Investors (WINV), Concepta PLC (CPT.L) (CPT), Chrysalis VCT (CYS), Management Resource Solutions (MRS), and Ormonde Mining (ORM). These companies are all part of the "trading" industry. EARNZ vs. Akers Biosciences TP Group Appscatter Group Metal Tiger Pebble Beach Systems Group Worsley Investors Concepta PLC (CPT.L) Chrysalis VCT Management Resource Solutions Ormonde Mining EARNZ (LON:EARN) and Akers Biosciences (LON:AKR) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation. Which has higher valuation and earnings, EARN or AKR? Akers Biosciences has higher revenue and earnings than EARNZ. Akers Biosciences is trading at a lower price-to-earnings ratio than EARNZ, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEARNZN/AN/A-£2.32M£0.747.16Akers Biosciences£2.32M0.00N/A-£129.60N/A Is EARN or AKR more profitable? Akers Biosciences' return on equity of 0.00% beat EARNZ's return on equity.Company Net Margins Return on Equity Return on Assets EARNZN/A -128.75% -43.59% Akers Biosciences N/A N/A N/A Does the MarketBeat Community prefer EARN or AKR? Akers Biosciences received 149 more outperform votes than EARNZ when rated by MarketBeat users. CompanyUnderperformOutperformEARNZN/AN/AAkers BiosciencesOutperform Votes14958.20% Underperform Votes10741.80% Do institutionals & insiders believe in EARN or AKR? 39.7% of EARNZ shares are owned by institutional investors. 30.0% of EARNZ shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer EARN or AKR? In the previous week, EARNZ's average media sentiment score of 0.00 equaled Akers Biosciences'average media sentiment score. Company Overall Sentiment EARNZ Neutral Akers Biosciences Neutral SummaryEARNZ and Akers Biosciences tied by winning 4 of the 8 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get EARNZ News Delivered to You Automatically Sign up to receive the latest news and ratings for EARN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EARN vs. The Competition Export to ExcelMetricEARNZShell Companies IndustryFinancial SectorLON ExchangeMarket Cap£5.42M£56.83M£3.71B£1.88BDividend YieldN/A4.97%4.42%5.54%P/E Ratio7.1635.27419.531,810.29Price / SalesN/A620.301,744.90382,807.21Price / CashN/A164.8552.3428.42Price / Book1.063.771.372.91Net Income-£2.32M-£2.05M£359.98M£156.83M7 Day Performance-3.64%-0.17%-1.62%-1.92%1 Month Performance-5.36%2.44%0.70%17.93%1 Year PerformanceN/A-0.30%9.94%29.50% EARNZ Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EARNEARNZN/AGBX 5.30-4.5%N/AN/A£5.42MN/A7.1611AKRAkers BiosciencesN/AGBX 57.50flatN/A+0.0%£21.64M£2.32M-0.44120TPGTP GroupN/AGBX 2.20flatN/A+0.0%£17.14M£45.09M-2.201,110High Trading VolumeAPPSAppscatter GroupN/AGBX 17.25flatN/A+0.0%£16.74M£758,102.00-1.25840MTRMetal TigerN/AGBX 9.06+9.8%N/AN/A£15.35M£-5,900,000.00-226.508Gap UpHigh Trading VolumePEBPebble Beach Systems GroupN/AGBX 9.50flatN/A+37.3%£11.83M£12.16M950.0060WINVWorsley InvestorsN/AGBX 30.70+4.4%N/A+0.1%£10.36M£742,000.001,023.332Gap UpCPTConcepta PLC (CPT.L)N/AGBX 1.98+23.8%N/AN/A£10.25M£28,960.00-2.831,650Gap UpHigh Trading VolumeCYSChrysalis VCTN/AGBX 32.50flatN/AN/A£9.25M£789,000.0065.0017MRSManagement Resource SolutionsN/AGBX 2.55flatN/A+0.0%£5.70MN/A1.3412,200ORMOrmonde MiningN/AGBX 0.75flatN/AN/A£3.54MN/A-2.506 Related Companies and Tools Related Companies AKR Alternatives TPG Alternatives APPS Alternatives MTR Alternatives PEB Alternatives WINV Alternatives CPT Alternatives CYS Alternatives MRS Alternatives ORM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:EARN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EARNZ plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EARNZ With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EARN Stock Alerts